ZPRW:F:F-SPDR® MSCI Europe Value UCITS ETF EUR Acc (EUR)

ETF | Others |

Last Closing

USD 54.79

Change

+0.16 (+0.29)%

Market Cap

USD 0.02B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

+0.20 (+0.04%)

USD 101.74B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.54 (+1.07%)

USD 101.37B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.86 (+1.54%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.32 (+2.16%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

+0.02 (+0.33%)

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

+3.06 (+3.33%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+2.50 (+1.10%)

USD 45.80B
0ZC:F Zscaler Inc

+3.55 (+1.74%)

USD 37.92B
BSND:F Danone SA

N/A

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B

ETFs Containing ZPRW:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.98% 89% A- 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.98% 88% B+ 77% C+
Trailing 12 Months  
Capital Gain 13.88% 86% B+ 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.88% 83% B 65% D
Trailing 5 Years  
Capital Gain 103.30% 91% A- 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 103.30% 91% A- 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 13.24% 83% B 72% C
Dividend Return 13.24% 80% B- 64% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.47% 53% F 86% B+
Risk Adjusted Return 106.19% 94% A 95% A
Market Capitalization 0.02B 9% A- 17% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.